止血和組織密封劑市場：按產品類型、應用、最終用戶和地區分類

Hemostasis and Tissue Sealing Agents Market, By Product Type, By Application, By End User, and By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

止血和組織密封劑市場預計到 2026 年將達到 40 億美元，到 2033 年將達到 59.3 億美元。預計從 2026 年到 2033 年，該市場將以 5.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	40億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.80%	2033年市場規模預測：	59.3億美元

止血和組織封閉劑在外科手術中發揮著至關重要的作用，它們能夠幫助外科醫生控制出血並封閉組織。其作用機轉是在切口和傷口上形成保護層，並促進人體自身的凝血過程。常用的止血和組織封閉產品包括密封劑、黏合劑、纖維蛋白貼片、膠原蛋白溶液和可吸收凝膠。全球止血和組織封閉市場持續成長，這主要得益於包括心血管外科、整形外科、神經血管外科和普通外科在內的各個外科專科對更有效的止血解決方案的需求不斷成長。

市場動態：

止血劑和組織密封劑市場的主要促進因素包括全球外科手術數量的快速成長、微創手術日益普及、新興國家醫療保健成本不斷攀升以及技術進步帶來的產品線改進。然而，產品召回（尤其是因安全問題導致的召回）、嚴格的監管標準以及主要非專利生產商的價格壓力等因素也構成了重大挑戰。另一方面，持續的研發投入，致力於開發具有更優療效的新一代止血劑和組織密封膠，為市場相關人員開闢了新的機會。此外，組織黏合劑在傷口修復領域的應用不斷擴展，也為止血劑和組織密封膠市場的成長提供了極具吸引力的機會。

本研究的主要特點：

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務績效和策略等參數，介紹了全球止血和組織密封市場主要參與者的概況。
本研究涵蓋的主要公司包括 Ethicon（強生公司子公司）、Baxter International、CryoLife、B. Braun Melsungen AG、Covidien（現為Medtronic公司子公司）、Integra Life Sciences、輝瑞、BD、Teleflex 和 Arch Therapeutics。
本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
本報告針對全球止血和組織密封劑市場，旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過對全球止血和組織密封市場進行分析時所使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Ethicon（a subsidiary of Johnson & Johnson）
Baxter International
CryoLife
B.Braun Melsungen AG
Covidien（now part of Medtronic）
Integra LifeSciences
Pfizer Inc.
BD
Teleflex
Arch Therapeutics

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1567

Hemostasis And Tissue Sealing Agents Market is estimated to be valued at USD 4.00 Bn in 2026 and is expected to reach USD 5.93 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.00 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 5.93 Bn

Hemostasis and tissue sealing agents play a vital role in surgical procedures by enabling surgeons to control bleeding and seal tissues. They work by forming a protective layer over incisions and wounds to accelerate the body's natural clotting process. Some commonly used hemostasis and tissue sealing products include sealants, glues, fibrin patches, collagen-based solutions, and absorbable gels. The global hemostasis and tissue sealing agents market has been growing in response to the rising need for more effective hemorrhage management solutions across various surgical specialties like cardiovascular, orthopedic, neurovascular, and general surgeries.

Market Dynamics:

The key drivers fueling the hemostasis and tissue sealing agents market include rapid growth in surgical procedures globally, increasing preference for minimally invasive surgeries, rising healthcare spending in emerging nations, and technological advancements leading to improved product portfolios. However, factors such as product recalls owing to safety concerns, stringent regulatory norms, and price pressures from large generic manufacturers pose significant challenges. On the positive side, ongoing research and development towards developing next-gen hemostats and sealants with superior efficacy is opening new avenues for market players. Growing applications of tissue adhesives in traumatic injury repair also present attractive opportunities for growth of hemostasis and tissue sealing agents market.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hemostasis and tissue sealing agents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Ethicon (a subsidiary of Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now part of Medtronic), Integra LifeSciences, Pfizer, BD, Teleflex and Arch Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hemostasis and tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis and tissue sealing agents market

Detailed Segmentation:

By Product Type (Revenue, USD Bn, 2021 - 2033)
Topical Hemostats & Adhesives
Tissue Sealing Agents
By Application (Revenue, USD Bn, 2021 - 2033)
Cardiovascular Surgery
Orthopedic Surgery
General Surgery
Neurosurgery
Others
By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Ethicon (a subsidiary of Johnson & Johnson)
Baxter International
CryoLife
Braun Melsungen AG
Covidien (now part of Medtronic)
Integra LifeSciences
Pfizer
BD
Teleflex
Arch Therapeutics

Report Description
- Market Definition and Scope
Executive Summary
- Global Hemostasis and Tissue Sealing Agents Market , By Product Type
- Global Hemostasis and Tissue Sealing Agents Market , By Application
- Global Hemostasis and Tissue Sealing Agents Market , By End User
- Global Hemostasis and Tissue Sealing Agents Market , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Hemostasis and Tissue Sealing Agents Market, By Product Type, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Topical Hemostats & Adhesives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Tissue Sealing Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Hemostasis and Tissue Sealing Agents Market, By Application, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Hemostasis and Tissue Sealing Agents Market, By End User, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Hemostasis and Tissue Sealing Agents Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Ethicon (a subsidiary of Johnson & Johnson)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CryoLife
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B.Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covidien (now part of Medtronic)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teleflex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arch Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies